Curasight
Curasight is founded in 2013 in Denmark based on a strong understanding of nuclear medicines and more than a decade of research at Copenhagen’s University hospital, Rigshospitalet and the University of Copenhagen, where the potential of targeting the urokinase-type plasminogen activator receptor (uPAR) in solid cancer tumors was identified. Led by Professor Andreas Kjær (CSO & Co-founder), the research demonstrated how uPAR could be used not only to visualize aggressive cancer biology through PET imaging, but also as a highly selective target for radionuclide therapy. These insights formed the basis for Curasight’s theranostic approach and the establishment of the company. Since its establishment, Curasight has focused on advancing a uPAR-based platform combining diagnostic uPAR-PET imaging (uTRACE®) and targeted radioligand therapy (uTREAT®) to identify, target, and eliminate all types of aggressive solid tumors with unmatched precision. Following its 2020 listing on Spotlight Market (~DKK 97 million raised), Curasight partnered uTRACE® with Curium in 2023 for global development and commercialization within diagnosis of prostate cancer. Through the years Curasight has conducted nine clinical trials (450 patients) with uTRACE® in eight solid cancer types, demonstrating favorable biodistribution (precision) and safety data across solid tumors. Curasight initiated its first Phase I uTREAT® clinical trial in glioblastoma in 2025.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
8
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Curasight
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Curasight
3 distinct titles indexed · top 3 shown.
- 1()
- 1chief development officer
- 1chief development officer (cdo)
Sign up to unlock all 3 contacts at Curasight
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Curasight
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.